GGrantIndex
Sort

11,323 grants matching glioblastoma

Project 2: Overcoming drug-induced resistance to intrinsic apoptosis in glioblastoma

$403,620
David A. Nathanson · University Of California Los Angeles · P50 · FY2024 · CA

Improved Delivery of Gene Therapies to the Central Nervous System by Focused Ultrasound-Mediated Disruption of the Blood-Brain Barrier

$403,573
Nicholas E. Todd · Brigham And Women'S Hospital · R01 · FY2023 · NS

Amide Proton Transfer (APT) MRI of Brain Tumors at 3T

$403,535
Jinyuan Zhou · Johns Hopkins University · R01 · FY2019 · CA

Deciphering MDSC function for GBM targeting

$403,517
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · NS

EGFRvIII-targeted Bispecific T cell Engagers for brain tumors

$403,487
John H Sampson · Duke University · R01 · FY2016 · NS

Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2

$403,419
Dai Fukumura · Massachusetts General Hospital · R01 · FY2021 · NS

Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2

$403,419
Dai Fukumura · Massachusetts General Hospital · R01 · FY2022 · NS

Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2

$403,419
Dai Fukumura · Massachusetts General Hospital · R01 · FY2023 · NS

Role of MELK in glioblastomas

$403,410
Alexey V Terskikh · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · NS

Mouse models of glioma to study functional exRNA transfer to the microenvironmen

$403,400
Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2016 · CA

Small Molecule Activators of Procaspases as Anti-Cancer Agents

$403,284
Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2020 · CA

Small Molecule Activators of Procaspases as Anti-Cancer Agents

$403,281
Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2021 · CA

Project 3: Predicting therapeutic sensitivity in cancer

$403,256
Anna Lasorella · Columbia University Health Sciences · U54 · FY2015 · CA

Genetic Mouse Models of Glioma

$403,255
Luis F Parada · Ut Southwestern Medical Center · R01 · FY2010 · CA

Regulation of CXCR4 by cognate and non-cognate ligands

$403,128
Elias Lolis · Yale University · R01 · FY2010 · AI

Engineering and Evaluation of Human L-Methionase for Cancer Therapy

$403,071
George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2013 · CA

Targeting macrophage reprogramming in glioblastoma

$403,028
Peiwen Chen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS

Project 3: Metabolic imaging of TERT expression

$403,025
Sabrina Miriam Ronen · University Of California, San Francisco · P01 · FY2020 · CA

Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.

$402,908
Hernando Martin Lopez-Bertoni · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2021 · NS

Project 1: Targeting immunotherapy-induced resistance with DC vaccination and PD-1/CSF-1R inhibition

$402,824
Robert M Prins · University Of California Los Angeles · P50 · FY2025 · CA

Targeting Lag-3 and PD -1 in Myeloid Cells of GBM

$402,791
Michael Lim · Stanford University · R01 · FY2022 · NS

Project 2: Overcoming drug-induced resistance to intrinsic apoptosis in glioblastoma

$402,689
David A. Nathanson · University Of California Los Angeles · P50 · FY2025 · CA

Characterizing germline and somatic alterations by glioma subtypes and clinical outcome

$402,608
Melissa L Bondy · Baylor College Of Medicine · R01 · FY2019 · CA

Synergistic microglial activation and tumor cell killing for improved GBM response

$402,500
Vidyalakshmi Chandramohan · Duke University · R01 · FY2025 · NS

Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma

$402,500
Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS